Atypical antipsychotic Lumateperone beyond Schizophrenia: seeking clarity in a time of uncertainty
Lumateperone (ITI-007) is a serotonin 5HT2A tosylate salt with high affinity for dopamineD2 and D1 receptors and the serotonin transporter. It is unusual in that it controlsserotonin, dopamine, and glutamate neurotransmission concurrently, all of which havebeen impl...
Saved in:
Main Author: | Mohamed, Wael Mohamed Yousef |
---|---|
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/96215/9/96215_Atypical%20antipsychotic%20Lumateperone.pdf http://irep.iium.edu.my/96215/ https://osf.io/preprints/africarxiv/26xec/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical antipsychotic lumateperone effects on the adrenal gland with possible beneficial effect of quercetin co-administration
by: El-Haroun, Hala, et al.
Published: (2021) -
Pharmacotherapy of alzheimer’s disease: seeking clarity in a time of uncertainty
by: Ibrahim, Nurul Husna, et al.
Published: (2020) -
Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia
by: Said, M.A., et al.
Published: (2013) -
Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia
by: Lee, C., et al.
Published: (2006) -
Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
by: Said, Mas Ayu, et al.
Published: (2012)